Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Invested Capital: 2011-2025

Historic Invested Capital for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to $240.3 million.

  • Mimedx Group's Invested Capital rose 30.70% to $240.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.3 million, marking a year-over-year increase of 30.70%. This contributed to the annual value of $212.1 million for FY2024, which is 10.06% up from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's Invested Capital is $240.3 million, which was up 10.30% from $217.9 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Invested Capital registered a high of $240.3 million during Q3 2025, and its lowest value of $29.0 million during Q3 2022.
  • In the last 3 years, Mimedx Group's Invested Capital had a median value of $183.9 million in 2024 and averaged $154.1 million.
  • As far as peak fluctuations go, Mimedx Group's Invested Capital plummeted by 59.08% in 2021, and later surged by 529.67% in 2023.
  • Mimedx Group's Invested Capital (Quarterly) stood at $48.2 million in 2021, then crashed by 36.51% to $30.6 million in 2022, then skyrocketed by 529.67% to $192.7 million in 2023, then grew by 10.06% to $212.1 million in 2024, then surged by 30.70% to $240.3 million in 2025.
  • Its Invested Capital stands at $240.3 million for Q3 2025, versus $217.9 million for Q2 2025 and $203.9 million for Q1 2025.